Top Stories
-
At Columbia, patients with brain cancer will be able to participate in a new type of clinical trial that promises to speed up the development of better drugs for glioblastoma.
Topic
-
Fewer than 1 in 10 patients with glioblastoma—the most common type of brain cancer—respond to immunotherapy; a new study reveals how to detect patients who may respond.
Topic
-
Though far from the most common form of cancer, brain cancers are uniquely difficult to treat. Columbia scientists are researching multiple new ways to attack the tumors.
Topic
-
The fusion of two adjacent genes can cause cancer by kicking mitochondria into overdrive and increasing the amount of fuel available for rampant cell growth.
Topic
Latest News
- January 28, 2016
A comprehensive analysis of the molecular characteristics of gliomas—the most common malignant brain tumor—explains why some patients diagnosed with slow-growing (low-grade) tumors quickly succumb to the disease while others with more aggressive (high-grade) tumors survive for many years.
Topic
- February 9, 2015
The drug Gleevec is well known not only for its effectiveness against leukemia. A similar drug might be able to tame some brain cancers, new research from Columbia University Medical Center has shown.
Topic
- July 30, 2014
Columbia experts worked together to offer an innovative option to a pregnant woman needing radiation therapy for a fast-growing brain tumor.
Topic
- August 29, 2013
With an HHMI fellowship, Columbia medical student Eli Sayegh is taking a year off from school to research a new theory about brain cancer.
Topic
- August 5, 2013
A study has found 18 new genes that drive an aggressive form of brain cancer, doubling the number of known driver genes of glioblastoma.
Topic
- March 5, 2013
Scientists discovered how common genetic mutations in Parkinson’s disease damage brain cells
Topic
- February 20, 2013
Omega-3 lipid emulsions protect brain after stroke in mouse study
Topic
- February 19, 2013
It's not just amyloid; white matter hyperintensities may be a second necessary factor for the development of Alzheimer’s.
Topic
- February 19, 2013
Dr. Carla Shatz Honored With the Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology
Topic
- February 13, 2013
Study in Nature could lead to taste modulators to help control our appetite for salty food
Topic
